quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:11:10·78d
INSIDERFiling
SI-BONE Inc. logo

Director Dunn Jeffrey W sold $5,532 worth of shares (337 units at $16.42), decreasing direct ownership by 3% to 9,970 units (SEC Form 4)

SIBN· SI-BONE Inc.
Health Care
Original source

Companies

  • SIBN
    SI-BONE Inc.
    Health Care

Recent analyst ratings

  • Jan 27UpdateTD Cowen$21.00
  • Aug 6UpdateNeedham$19.00
  • Mar 28UpdatePiper Sandler$25.00
  • Oct 12UpdateJefferies$20.00
  • Apr 7UpdateCantor Fitzgerald$34.00
  • Mar 1UpdateMorgan Stanley$28.00

Related

  • SEC2d
    SEC Form DEFA14A filed by SI-BONE Inc.
  • SEC2d
    SEC Form DEF 14A filed by SI-BONE Inc.
  • PR3d
    SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
  • INSIDER14d
    SEC Form 4 filed by Hinckley Greg K
  • INSIDER20d
    SEC Form 4 filed by Maheshwari Anshul
  • INSIDER20d
    SEC Form 4 filed by Pisetsky Michael A.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by SI-BONE Inc.
  • INSIDER41d
    Director Nishimura Mika sold $56,700 worth of shares (4,100 units at $13.83), decreasing direct ownership by 11% to 32,716 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022